Literature DB >> 22150081

The AKT1 gene is associated with attention and brain morphology in schizophrenia.

Kazutaka Ohi1, Ryota Hashimoto, Yuka Yasuda, Motoyuki Fukumoto, Kiyotaka Nemoto, Takashi Ohnishi, Hidenaga Yamamori, Hidetoshi Takahashi, Naomi Iike, Kouzin Kamino, Tetsuhiko Yoshida, Michiyo Azechi, Koji Ikezawa, Hitoshi Tanimukai, Shinji Tagami, Takashi Morihara, Masayasu Okochi, Toshihisa Tanaka, Takashi Kudo, Masao Iwase, Hiroaki Kazui, Masatoshi Takeda.   

Abstract

OBJECTIVES: A meta-analysis of the associations between genetic variants in the AKT1 gene and schizophrenia found that a single nucleotide polymorphism (SNP5; rs2494732) was associated with schizophrenia in Asian populations.
METHODS: In this study, we investigated the effects of this SNP on memory and attentional performance and brain structure using magnetic resonance imaging in a Japanese population (117 patients with schizophrenia and 189 healthy subjects).
RESULTS: The memory performance, particularly attention/concentration score, measured by the Wechsler Memory Scale-Revised in A carriers of SNP5, which was found to be enriched in patients with schizophrenia, was lower than that in individuals with the G/G genotype. We confirmed the association of the SNP with attentional performance using the Continuous Performance Test, which assessed sustained attention and vigilance of attentional function. Patients with A allele demonstrated lower attentional performance than patients with the G/G genotype. Patients with the A allele had smaller gray matter volumes in the right inferior parietal lobule related to attentional processes and in the frontostriatal region related to different SNPs in AKT1 than patients with the G/G genotype.
CONCLUSIONS: Our results suggest that a genetic variant of AKT1 might be associated with attentional deficits and brain morphological vulnerability in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22150081     DOI: 10.3109/15622975.2011.591826

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  14 in total

1.  New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.

Authors:  Elena Shumay; Corinde E Wiers; Ehsan Shokri-Kojori; Sung Won Kim; Colin A Hodgkinson; Hui Sun; Dardo Tomasi; Christopher T Wong; Daniel R Weinberger; Gene-Jack Wang; Joanna S Fowler; Nora D Volkow
Journal:  J Neurosci       Date:  2017-04-17       Impact factor: 6.167

2.  Cognitive inflexibility in Japanese adolescents and adults with autism spectrum disorders.

Authors:  Yuka Yasuda; Ryota Hashimoto; Kazutaka Ohi; Hidenaga Yamamori; Michiko Fujimoto; Satomi Umeda-Yano; Haruo Fujino; Masatoshi Takeda
Journal:  World J Psychiatry       Date:  2014-06-22

3.  Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression.

Authors:  Robert E Featherstone; Valerie M Tatard-Leitman; Jimmy D Suh; Robert Lin; Irwin Lucki; Steven J Siegel
Journal:  Psychopharmacology (Berl)       Date:  2013-02-08       Impact factor: 4.530

4.  Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Yuka Yasuda; Kiyotaka Nemoto; Takashi Ohnishi; Motoyuki Fukumoto; Hidenaga Yamamori; Satomi Umeda-Yano; Takeya Okada; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

Review 5.  Imaging genetics and psychiatric disorders.

Authors:  R Hashimoto; K Ohi; H Yamamori; Y Yasuda; M Fujimoto; S Umeda-Yano; Y Watanabe; M Fukunaga; M Takeda
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

6.  Common variants at 1p36 are associated with superior frontal gyrus volume.

Authors:  R Hashimoto; M Ikeda; F Yamashita; K Ohi; H Yamamori; Y Yasuda; M Fujimoto; M Fukunaga; K Nemoto; T Takahashi; M Tochigi; T Onitsuka; H Yamasue; K Matsuo; T Iidaka; N Iwata; M Suzuki; M Takeda; K Kasai; N Ozaki
Journal:  Transl Psychiatry       Date:  2014-10-21       Impact factor: 6.222

7.  Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects.

Authors:  Yoshihiro Kamada; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Tetsuo Takehara; Yuko Fujita; Kenji Hashimoto; Eiji Miyoshi
Journal:  BBA Clin       Date:  2016-02-23

Review 8.  A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.

Authors:  Kazutaka Ohi; Chika Sumiyoshi; Haruo Fujino; Yuka Yasuda; Hidenaga Yamamori; Michiko Fujimoto; Tomiki Sumiyoshi; Ryota Hashimoto
Journal:  Front Psychiatry       Date:  2017-12-22       Impact factor: 4.157

9.  Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia.

Authors:  Masataka Kikuchi; Kenichiro Miura; Kentaro Morita; Hidenaga Yamamori; Michiko Fujimoto; Masashi Ikeda; Yuka Yasuda; Akihiro Nakaya; Ryota Hashimoto
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

10.  The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Umeda-Yano; Masaki Fukunaga; Yoshiyuki Watanabe; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  Behav Brain Funct       Date:  2013-10-25       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.